B. Riley Estimates Novavax’s FY2024 Earnings (NASDAQ:NVAX)
Novavax, Inc. (NASDAQ:NVAX – Free Report) – B. Riley decreased their FY2024 earnings estimates for Novavax in a report issued on Thursday, February 20th. B. Riley analyst M. Mamtani now anticipates that the biopharmaceutical company will post earnings per share of ($1.83) for the year, down from their prior forecast of ($1.41). The consensus estimate […]
Novavax, Inc. (NASDAQ:NVAX – Free Report) – B. Riley decreased their FY2024 earnings estimates for Novavax in a report issued on Thursday, February 20th. B. Riley analyst M. Mamtani now anticipates that the biopharmaceutical company will post earnings per share of ($1.83) for the year, down from their prior forecast of ($1.41). The consensus estimate […]
